Drug Profile
Selone
Alternative Names: SeloneLatest Information Update: 30 Oct 2008
Price :
$50
*
At a glance
- Originator ADVENTRX Pharmaceuticals; University of Southern California
- Developer ADVENTRX Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Jan 2007 Preclinical development is ongoing
- 20 Jun 2003 Biokeys Pharmaceuticals is now called ADVENTRX Pharmaceuticals
- 10 Jul 2002 This compound is still in active development